The company is paying a high price to get into snacking with the acquisition of the Twinkies maker.

Recent hiccups probably won’t derail the firm’s restructuring, but the stock could struggle without further concrete signs of progress—and a healthier China.

The media glitz of top car shows has faded, but the format has staying power as a marketing event for consumers with cash to spend.

The valuations for both companies have come in below expectations, reflecting a cautious outlook on Wall Street as firms start to go public again after a fallow patch.

Corporate policy changes, an endorsement from Warren Buffett and low valuations have propelled Japanese stocks.

Oil prices are at their highest level this year.

Competitive yields are tough to find in the stock market these days. For investors who aren’t averse to risk, business development companies offer an exception.

The F.D.A. is expected to approve a new round of shots by Pfizer and Moderna as early as Monday to prepare Americans for the fall and winter season when infections usually tick upward.

The federal government’s first monopoly trial this century will feature top tech executives, experienced litigators and an Obama-appointed judge.

Administrative layoffs have been among the first cuts for hospital systems, including MultiCare, Overlake Medical Center & Clinics and Seattle Children’s, as they continue to address steep financial losses.